Visco Vision Inc. · TWSE:6782
Visco Vision — KGI Securities Online Investor Conference (November 2025)
11 slides from Visco Vision's conference presentation, Nov 21, 2025
Slide 1: Visco Vision Inc. 2025 Q4 Investor Conference
Visco Vision Inc. 2025 Q4 Investor Conference © 2025 VISCO VISION INC. Confidential Stock NO. 6 78 2
Slide 2: Disclaimer
Disclaimer Visco’s statements of its current expectations are forward-looking statements subject to significant risks and uncertainties and actual results may differ materially from those contained in the forward- looking statements. 本簡報係公司於簡報當時之主、客觀因素，對過去、現在與未來之營運彙總與評估；其中若含有前瞻性之論述，將 受風險、不確定性及推論所影響，
Slide 3: 2025 Biotech Value Competitiveness Survey
2025 “Biotech Value Competitiveness” Survey • By leveraging financial data, operational risk analysis, and ESG assessments, the comprehensive value proposition of Taiwan’s biotechnology industry is evaluated through the “Taiwan BIG Score” methodology . This assessment is structured around four core
Slide 4: Financial Results & Business Overview
Financial Results & Business Overview
Slide 5: Income Statement
Income Statement 3Q 25 2Q 25 QoQ 3Q 24 YoY (In Millions) AMT. % AMT. % Net revenue 1,132 100% 1,076 100% 56 5% 1,037 100% 95 9% Cost of revenue (609) 54% (575) 54% (34) 6% (667) 64% 58 -9% Gross profit 523 46% 501 46% 23 4% 370 36% 153 41% Operating expense (186) 16% (196) 18% 10 -5% (173) 17% (13)
Slide 6: Income Statement
Income Statement 2024 Q1~Q3 YoY 2025 Q1~Q3 (In Millions) AMT. % Net revenue 3,156 100% 2,758 100% 397 14% Cost of revenue (1,747) 55% (1,675) 61% (72) 4% Gross profit 1,409 45% 1,083 39% 326 30% Operating expense (568) 18% (468) 17% (100) 21% Income from operations 841 27% 616 22% 226 37% Non-operat
Slide 7: Revenue by Region
Revenue by Region (In Millions) 3Q 24 4Q 24 1Q 25 2Q 25 3Q 25 Amount % Amount % Amount % Amount % Amount % Asia 755 73% 626 69% 698 73% 789 73% 873 77% Europe 215 21% 193 21% 185 20% 189 18% 233 21% Americas 68 7% 94 10% 64 7% 98 9% 26 2% Total 1,037 100% 913 100% 947 100% 1,076 100% 1,132 100%
Slide 8: Operation Overview
Operation Overview mm Revenue (In Million) 1,037 913 947 1,076 1,132 lm=mPAT (In Millions) 199 124 194 187 256 —EPS (NTD) 3.15 1.96 3.08 2.96 4.06 4.50 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50 0.00 VISCO See Comfortably
Slide 9: Balance Sheet
Balance Sheet Annual 2025.9.30 2025.6.30 QoQ 2024.12.31 Difference (In Millions) AMT. % AMT. % AMT. % AMT. % AMT. % Cash and financial assets-current 961 17% 939 17% 22 2% 805 15% 155 19% Accounts receivable 674 12% 516 9% 159 31% 441 8% 233 53% Inventories 615 11% 622 11% -6 -1% 593 11% 22 4% Inves
Slide 10: Q&A
Q&A
Slide 11: Thank You
Thank You www.viscovision.com.tw IR@viscovision.com.tw
Visco Vision — KGI Securities Online Investor Conference (November 2025) on 6ix